Actos
Product Images NDC 21695-147

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Actos (NDC 21695-147). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Fd156adc 3174 44da Bff7 Eeaef5983f18 01)

FDA Label Image

Figure (Fd156adc 3174 44da Bff7 Eeaef5983f18 02)

FDA Label Image

Actos 15mg Label (Fd156adc 3174 44da Bff7 Eeaef5983f18 03)

Actos 15mg Label (Fd156adc 3174 44da Bff7 Eeaef5983f18 03)
This is the description of Actos 15mg tablets. Each tablet contains Pioglitazone HCI. The tablet is white to off-white, round, convex, non-scored, and has "ACTOS" on one side and "15" on the other. These tablets are packaged by Physician Partner and manufactured by Takeda Pharmaceutical Company Ltd, Osaka, Japan. The product should be stored at a controlled room temperature of 15°-30°C (59°-86°F). Product ID: PA014715.*
FDA Label Image

Actos 30mg Label (Fd156adc 3174 44da Bff7 Eeaef5983f18 04)

Actos 30mg Label (Fd156adc 3174 44da Bff7 Eeaef5983f18 04)
This is a description of a medication called ACTOS. It is a tablet used to treat type 2 diabetes. Each tablet contains 30mg of Pioglitazone HCI. The tablets are white to off-white, round, flat, non-scored and have "ACTOS" on one side and "30" on the other. The product ID is PA014815 and it is manufactured by Takeda Pharmaceutical Company from Osaka, Japan. It is recommended to store the medication at a controlled room temperature of 15°-30°C (59°-86°F) and to keep it out of the reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.